Zurich Cantonal Bank’s Terns Pharmaceuticals TERN Stock Holding History

Zurich Cantonal Bank’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$798K	Buy	+15,146	New	+$622K	﹤0.01%	1563
2024 Q2	–	Sell	-7,782	Closed	-$51K	–	2718
2024 Q1	$51K	Sell	7,782 -1,568	-17%	-$10.2K	﹤0.01%	2561
2023 Q4	$60.7K	Sell	9,350 -1,829	-16%	-$9.67K	﹤0.01%	2577
2023 Q3	$56.2K	Sell	11,179 -276	-2%	-$1.75K	﹤0.01%	2573
2023 Q2	$100K	Buy	11,455 +8,973	+362%	+$105K	﹤0.01%	2354
2023 Q1	$29.4K	Sell	2,482 -2,568	-51%	-$24.5K	﹤0.01%	2704
2022 Q4	$51.4K	Buy	+5,050	New	+$33.6K	﹤0.01%	2591

Other funds holding TERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Zurich Cantonal Bank's TERN Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Terns Pharmaceuticals (TERN) in Q1 2026: 15,146 shares worth $798K. The stake represents ﹤0.01% of the portfolio and ranks #1563 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in TERN as recently as Q1 2024.

Zurich Cantonal Bank first reported a position in TERN in Q4 2022 and has held it in 7 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

Zurich Cantonal Bank held 15,146 shares of Terns Pharmaceuticals worth $798K as of Q1 2026.
Terns Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
Terns Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1563 holding.
Zurich Cantonal Bank first reported a position in Terns Pharmaceuticals in Q4 2022 and has held it in 7 quarters since.
317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.